Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes

Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes

Item
http://www.wikidata.org/entity/Q28259650
Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formationEngineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?Identification of the nuclear localization signal of SALL4B, a stem cell transcription factorSALL4, the missing link between stem cells, development and cancerRole of SALL4 in the progression and metastasis of colorectal cancerSignificance of oncogenes and tumor suppressor genes in AML prognosis.Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway.Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.Aberrantly Expressed SALL4 Promotes Cell Proliferation via β-Catenin/c-Myc Pathway in Human Choriocarcinoma Cells.Functional and clinical significance of SALL4 in breast cancer.Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.Immunoexpression of SALL4 in Wilms tumors and developing kidney.SALL4 as a new biomarker for early colorectal cancers.
P2860

Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes

Item
http://www.wikidata.org/entity/Q28259650
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Overexpression of the novel on ...... y in myelodysplastic syndromes
@ast
Overexpression of the novel on ...... y in myelodysplastic syndromes
@en
Overexpression of the novel on ...... y in myelodysplastic syndromes
@nl
type
label
Overexpression of the novel on ...... y in myelodysplastic syndromes
@ast
Overexpression of the novel on ...... y in myelodysplastic syndromes
@en
Overexpression of the novel on ...... y in myelodysplastic syndromes
@nl
prefLabel
Overexpression of the novel on ...... y in myelodysplastic syndromes
@ast
Overexpression of the novel on ...... y in myelodysplastic syndromes
@en
Overexpression of the novel on ...... y in myelodysplastic syndromes
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P921
P3181
P356
P1433
P1476
Overexpression of the novel on ...... y in myelodysplastic syndromes
@en
P2093
P304
P31
P3181
P356
10.1016/J.CANCERGENCYTO.2009.06.006
P407
P433
P478
P577
P698
P921